My Research Webinar – UK Early Career Researchers Cancer Group

Wednesday 17th January 2024 6-7pm GMT

 

Register for the Session HERE: https://www.bopa.org.uk/webinarsignupform/

 

We would like to invite you to join our  ‘My Research’ sessions. These sessions are delivered by members that have undertaken an audit or evaluation. They will spend time describing their career pathway and discuss the research methods that they used. There will be time for detailed questions following the talk. These sessions will enable members to learn about quantitative and qualitative methods and the learning may guide and help you in your future projects. We also hope that this will be a good opportunity to learn about different career pathways in cancer pharmacy.

 

The session will be delivered by:

Dr Harshani Green, clinical oncology fellow, Royal Marsden Hospital London

Dr Matthew Fok, PhD surgical fellow, University of Liverpool

 

The speakers represent UK ECRC which is originally a National Cancer Research Institute (NCRI) initiative, launched 2 years ago. This is a group of >600 multidisciplinary members across the UK, all with an active interest in cancer research and early in our research careers.

 

Matthew Fok is a PhD surgical fellow based at the University of Liverpool and Harshani Green is a clinical oncology fellow based at the Royal Marsden Hospital London.  They are co-leading the group and have a multidisciplinary advisory committee that aims to be representative of the diversity of our group (scientists, nurses, AHP, doctors, psychologists etc). They are all volunteers and run the group in our spare time.

 The group aims to be able to offer:

  1. Opinion surveys (e.g. explore barriers to careers in research, identify areas of interest, gaps in skillsets)
  2. Increase awareness of opportunities around the UK (aiming to reduce inequality of opportunity)
  3. Training opportunities, links to industry and a framework to support proposals for early-career investigator-led projects or entrepreneurial ideas.  
  4. Offer contribution to a breadth of research areas and would be potentially suitable for researchers alongside service jobs.  Alongside biological/translational and clinical trials research, this could potentially include support with:
  • Health Services Research
  • Clinical Epidemiology
  • Implementation Science
  • Health Economics
  • Global Health Research

 

Please Note:

-Webinars will start at 18:00 GMT and will last about 30 minutes to 1 hour

-The Zoom link for the webinar will be sent on the day of the event around 17:00pm (if you would like the link before this time please email [email protected])

-This webinar is FREE to access for BOPA Paid Members or Free Associates

-Webinars will be recorded and accessible from the BOPA eLearning section of the website via this LINK

 

The BOPA Research Subcommittee

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article